S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
Stock market today: Another winning week for Wall Street ends with more records
The Ultimate Passive Income Play (Ad)
Latest freight railroad layoffs and Wall Street pressure renew concerns about safety and service
One year after buying a failed bank, New York Community Bancorp is struggling
The Ultimate Passive Income Play (Ad)
Dell, NetApp rise; Ginkgo Bioworks, New York Community Bancorp fall, Friday, 3/1/2024
How major US stock indexes fared Friday, 3/1/2024
Billionaires Are Now FLOODING Into Gold (Ad)
China pledges to increase opportunities for foreign companies as it seeks to boost its economy
Brazil's economy grows 2.9% in Lula's 1st year, beating expectations
S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
Stock market today: Another winning week for Wall Street ends with more records
The Ultimate Passive Income Play (Ad)
Latest freight railroad layoffs and Wall Street pressure renew concerns about safety and service
One year after buying a failed bank, New York Community Bancorp is struggling
The Ultimate Passive Income Play (Ad)
Dell, NetApp rise; Ginkgo Bioworks, New York Community Bancorp fall, Friday, 3/1/2024
How major US stock indexes fared Friday, 3/1/2024
Billionaires Are Now FLOODING Into Gold (Ad)
China pledges to increase opportunities for foreign companies as it seeks to boost its economy
Brazil's economy grows 2.9% in Lula's 1st year, beating expectations
S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
Stock market today: Another winning week for Wall Street ends with more records
The Ultimate Passive Income Play (Ad)
Latest freight railroad layoffs and Wall Street pressure renew concerns about safety and service
One year after buying a failed bank, New York Community Bancorp is struggling
The Ultimate Passive Income Play (Ad)
Dell, NetApp rise; Ginkgo Bioworks, New York Community Bancorp fall, Friday, 3/1/2024
How major US stock indexes fared Friday, 3/1/2024
Billionaires Are Now FLOODING Into Gold (Ad)
China pledges to increase opportunities for foreign companies as it seeks to boost its economy
Brazil's economy grows 2.9% in Lula's 1st year, beating expectations
S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
Stock market today: Another winning week for Wall Street ends with more records
The Ultimate Passive Income Play (Ad)
Latest freight railroad layoffs and Wall Street pressure renew concerns about safety and service
One year after buying a failed bank, New York Community Bancorp is struggling
The Ultimate Passive Income Play (Ad)
Dell, NetApp rise; Ginkgo Bioworks, New York Community Bancorp fall, Friday, 3/1/2024
How major US stock indexes fared Friday, 3/1/2024
Billionaires Are Now FLOODING Into Gold (Ad)
China pledges to increase opportunities for foreign companies as it seeks to boost its economy
Brazil's economy grows 2.9% in Lula's 1st year, beating expectations
NYSE:USNA

USANA Health Sciences (USNA) Stock Price, News & Analysis

$48.32
+0.06 (+0.12%)
(As of 03/1/2024 ET)
Today's Range
$47.61
$48.42
50-Day Range
$46.47
$54.45
52-Week Range
$44.01
$69.60
Volume
85,919 shs
Average Volume
67,958 shs
Market Capitalization
$929.68 million
P/E Ratio
14.64
Dividend Yield
N/A
Price Target
$48.00

USANA Health Sciences MarketRank™ Stock Analysis

Analyst Rating
Moderate Buy
2.50 Rating Score
Upside/​Downside
0.7% Downside
$48.00 Price Target
Short Interest
Healthy
1.46% of Float Sold Short
Dividend Strength
N/A
Sustainability
-2.09
Upright™ Environmental Score
News Sentiment
-0.04mentions of USANA Health Sciences in the last 14 days
Based on 5 Articles This Week
Insider Trading
Selling Shares
$15,516 Sold Last Quarter
Proj. Earnings Growth
14.65%
From $2.73 to $3.13 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

3.08 out of 5 stars

Medical Sector

412th out of 951 stocks

Medicinals & Botanicals Industry

2nd out of 11 stocks


USNA stock logo

About USANA Health Sciences Stock (NYSE:USNA)

USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional, personal care, and skincare products. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers comprising targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and foods that include meal replacement shakes, snack bars, and other related products. It also provides Celavive, a skin care regimen for various skin care types and ethnicities; and other products for prenatal, infant, and young child age groups. In addition, the company offers materials and online tools to assist associates in building their businesses, as well as in marketing products. It offers its products directly in the Asia Pacific, the Americas, and Europe, as well as online. The company has a research collaboration agreement with Beijing University of Chinese Medicine; and National Sports Training Bureau. USANA Health Sciences, Inc. was founded in 1992 and is headquartered in Salt Lake City, Utah.

USNA Stock Price History

USNA Stock News Headlines

Kevin Guest Says Leap Forward on Leap Day
USANA Health Sciences (NYSE:USNA) Price Target Cut to $48.00
This is the #1 Stock to Buy for the AI Tidal Wave
Marc Chaikin warned people about NVDA before its 2023 bull run - now he’s naming his next pick or the AI tidal wave. Learn more here.
Jim Simons Adjusts Position in Usana Health Sciences Inc
This is the #1 Stock to Buy for the AI Tidal Wave
Marc Chaikin warned people about NVDA before its 2023 bull run - now he’s naming his next pick or the AI tidal wave. Learn more here.
USANA Health Sciences Q4 Income Climbs, Beats estimates
USANA (NYSE:USNA) Q4 Sales Beat Estimates
Kevin Guest Names 2024 the Year of Connection
USANA Named a Best Company to Work For in Utah
See More Headlines
Receive USNA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for USANA Health Sciences and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
2/06/2024
Today
3/01/2024
Next Earnings (Estimated)
4/23/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Medicinals & botanicals
Sub-Industry
Personal Products
CUSIP
90328M10
Employees
1,900
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$48.00
High Stock Price Target
$48.00
Low Stock Price Target
$48.00
Potential Upside/Downside
-0.7%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.50
Research Coverage
2 Analysts

Profitability

Net Income
$63.79 million
Pretax Margin
11.12%

Debt

Sales & Book Value

Annual Sales
$921.01 million
Cash Flow
$4.42 per share
Book Value
$25.84 per share

Miscellaneous

Free Float
19,067,000
Market Cap
$929.68 million
Optionable
Optionable
Beta
0.88
These 7 Stocks Will Be Magnificent in 2024 Cover

With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.

Get This Free Report














USNA Stock Analysis - Frequently Asked Questions

Should I buy or sell USANA Health Sciences stock right now?

2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for USANA Health Sciences in the last twelve months. There are currently 1 hold rating and 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" USNA shares.
View USNA analyst ratings
or view top-rated stocks.

What is USANA Health Sciences' stock price target for 2024?

2 Wall Street research analysts have issued 12 month price objectives for USANA Health Sciences' shares. Their USNA share price targets range from $48.00 to $48.00. On average, they expect the company's share price to reach $48.00 in the next year. This suggests that the stock has a possible downside of 0.7%.
View analysts price targets for USNA
or view top-rated stocks among Wall Street analysts.

How have USNA shares performed in 2024?

USANA Health Sciences' stock was trading at $53.60 at the start of the year. Since then, USNA shares have decreased by 9.9% and is now trading at $48.32.
View the best growth stocks for 2024 here
.

Are investors shorting USANA Health Sciences?

USANA Health Sciences saw a decrease in short interest in the month of January. As of January 31st, there was short interest totaling 160,300 shares, a decrease of 19.2% from the January 15th total of 198,400 shares. Based on an average daily volume of 72,700 shares, the days-to-cover ratio is currently 2.2 days. Currently, 1.4% of the company's shares are sold short.
View USANA Health Sciences' Short Interest
.

When is USANA Health Sciences' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, April 23rd 2024.
View our USNA earnings forecast
.

How were USANA Health Sciences' earnings last quarter?

USANA Health Sciences, Inc. (NYSE:USNA) posted its quarterly earnings results on Tuesday, February, 6th. The company reported $0.87 EPS for the quarter, beating analysts' consensus estimates of $0.52 by $0.35. The company earned $221.08 million during the quarter, compared to analyst estimates of $206.70 million. USANA Health Sciences had a net margin of 6.93% and a trailing twelve-month return on equity of 13.49%.

What ETFs hold USANA Health Sciences' stock?
What guidance has USANA Health Sciences issued on next quarter's earnings?

USANA Health Sciences updated its FY 2024 earnings guidance on Tuesday, February, 6th. The company provided earnings per share (EPS) guidance of 2.400-3.000 for the period, compared to the consensus estimate of 2.940. The company issued revenue guidance of $850.0 million-$920.0 million, compared to the consensus revenue estimate of $912.3 million.

What is Kevin Guest's approval rating as USANA Health Sciences' CEO?

68 employees have rated USANA Health Sciences Chief Executive Officer Kevin Guest on Glassdoor.com. Kevin Guest has an approval rating of 99% among the company's employees. This puts Kevin Guest in the top 10% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of USANA Health Sciences own?

Based on aggregate information from My MarketBeat watchlists, some companies that other USANA Health Sciences investors own include International Business Machines (IBM), Gilead Sciences (GILD), NVIDIA (NVDA), AT&T (T), BioMarin Pharmaceutical (BMRN), Vertex Pharmaceuticals (VRTX), AbbVie (ABBV), Walt Disney (DIS), Intuitive Surgical (ISRG) and Johnson & Johnson (JNJ).

Who are USANA Health Sciences' major shareholders?

USANA Health Sciences' stock is owned by many different institutional and retail investors. Top institutional shareholders include Vanguard Group Inc. (8.27%), Pzena Investment Management LLC (3.98%), Dimensional Fund Advisors LP (3.54%), Pacer Advisors Inc. (1.76%), Charles Schwab Investment Management Inc. (1.16%) and Northern Trust Corp (0.64%). Insiders that own company stock include Brent Neidig, Daniel A Macuga, David Mulham Mulham, Feng Peng, Frederic J Winssinger, G Doug Iiekking, Gilbert A Fuller, Gilbert A Fuller, Jim Brown, John Turman Fleming, Joshua Foukas, Kevin Guest, Paul A Jones, Robert A Sinnott, Robert Auciaux, Walter Noot and Xia Ding.
View institutional ownership trends
.

How do I buy shares of USANA Health Sciences?

Shares of USNA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NYSE:USNA) was last updated on 3/2/2024 by MarketBeat.com Staff